Based on this incident, Sally who is a patient with liver cancer, she has been given 6 months to live. She started to search for any promising treatment which would give her hope to live more and improve her condition. She has been advised to start a medication which is manufactured in Europe and not approved by the FDA. Based on the previously mentioned incident, she has the right to get the FDA approval to import the required medication to treat her condition. Also, based on The Regulation Procedures Manual (RPM) under the entitled section “Coverage of Personal Importations,” which states the FDA should consider not taking enforcement actions against certain cases of importation, specifically when the intended use of the drug is unapproved and for a serious condition as in Sally's case for which effective treatment may not be available domestically either through commercial or clinical means. Also, when the product is considered not to represent an unreasonable risk. Moreover, when the individual seeking to import the product affirms in writing that it is for the patient's own use under the recommendation and the supervision of the health care provider. Although the PRM provides that the importation should generally not